Demand for CROs Rises to Strike Evolving Clinical Trial Models for Target Therapies

 

Demand for CROs Rises to Strike Evolving Clinical Trial Models for Target Therapies

SANTA CLARA, Calif., Feb. 3, 2020 /PRNewswire/ — With an overall R&D expenditure of $167 billion in 2018, the global healthcare industry is investing heavily in the development of novel therapies to …

More Demand for CROs Rises to Strike Evolving Clinical Trial Models for Target Therapies Videos

Leave a Reply